Published in Vaccine Weekly, January 24th, 2007
The new corporate headquarters will house approximately 300 employees.
Valeant Pharmaceuticals International (VRX) is a global, science-based specialty pharmaceutical company.
The company develops and manufactures a range of pharmaceutical products primarily in the areas of neurology, infectious disease and dermatology.
This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2007, Vaccine Weekly via NewsRx.com.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly